Mekanistic Therapeutics
Ann Arbor
About Mekanistic Therapeutics
Mekanistic is a biotechnology company that is redefining oncology. They offer a novel class of selective kinase inhibitors that are rationally designed to target EGFR and PI3K with a single molecule. They use computational tools and also design medications that perfectly fit within those sites to inhibit the spread of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $30.0M
- Last round: Series Unknown (Jun 2022)
- Website: mekanistic.com
- Phone: 734-998-8327
Industries & Categories
Biotechnology, Life Science, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/mekanistic-therapeutics-42460 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.